Document Detail

Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
MedLine Citation:
PMID:  17295757     Owner:  NLM     Status:  MEDLINE    
Non-alcoholic fatty liver disease has been associated with metabolic disorders, including central obesity, dyslipidemia, hypertension and hyperglycemia. Metabolic syndrome, obesity, and insulin resistance are major risk factors in the pathogenesis of non-alcoholic fatty liver disease. Non-alcoholic fatty liver disease refers to a wide spectrum of liver damage, ranging from simple steatosis to non-alcoholic steatohepatitis, advanced fibrosis and cirrhosis.
Giovanni Tarantino; Gennaro Saldalamacchia; Paolo Conca; Adriano Arena
Related Documents :
8748257 - Strategies for potential manipulation of anorexia during acute and chronic disease.
9059947 - Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship...
18081207 - Phenolic compounds: evidence for inhibitory effects against obesity and their underlyin...
3963957 - The relevance of iga deposits in vessel walls of clinically normal skin. a prospective ...
18690837 - Clinico-pathologic function of cerebral abc transporters - implications for the pathoge...
10737127 - Histopathology and apoe genotype of the first alzheimer disease patient, auguste d.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of gastroenterology and hepatology     Volume:  22     ISSN:  0815-9319     ISO Abbreviation:  J. Gastroenterol. Hepatol.     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-02-13     Completed Date:  2007-07-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8607909     Medline TA:  J Gastroenterol Hepatol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  293-303     Citation Subset:  IM    
Department of Clinical and Experimental Medicine, Federico II University Medical School, Naples, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Fatty Liver / epidemiology,  etiology*,  therapy
Insulin Resistance
Metabolic Syndrome X / complications*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Deficits in eye movement control in children with fetal alcohol spectrum disorders.
Next Document:  Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.